• TH
    • EN
    • Register
    • Login
    • Forgot Password
    • Help
    • Contact
  • Register
  • Login
  • Forgot Password
  • Help
  • Contact
  • EN 
    • TH
    • EN
View Item 
  •   Home
  • สถาบันวิจัยระบบสาธารณสุข (สวรส.) - Health Systems Research Institute (HSRI)
  • Research Reports
  • View Item
  •   Home
  • สถาบันวิจัยระบบสาธารณสุข (สวรส.) - Health Systems Research Institute (HSRI)
  • Research Reports
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Improvement of Clinical Outcome in Kidney Diseases via On-line Thai Glomerular Disease Registry

รัตนา ชวนะสุนทรพจน์; Ratana Chawanasuntorapoj; บุณยฤทธิ์ ชื่นสุชน; Boonyarit Cheunsuchon; ชาครีย์ กิติยากร, หม่อมหลวง; Thai Glomerular Disease Collaborative Network;
Date: 2559
Abstract
Background: End stage renal disease (ESRD) cause the high morbidity, mortality, and cost in health care system. The prevention of chronic kidney disease/ESRD is the early recognition and appropriate treatment of the etiology disease. Glomerulonephritis (GN) is the third most common cause of ESRD in Thailand comparable to the Western country. The development of qualified registry and GN network may improve the health care service and accurate epidemiological data that support the further studies in both clinical and translational research. Objective: To develop web-based On-line Thai Glomerular Disease Registry for studying the epidemiology and clinical outcomes of glomerular diseases in Thailand. To develop Thai Glomerular Disease Collaborative Network (TGDCN) through the country for creating the GN database and supporting together in taking care of the patients. To perform the clinical recommendation in GN management. Methods: TGDCN originally consists of 9 tertiary care centers. We developed the Web-based Online registry to collect the data from all native kidney biopsy-proven GN patients with aged > 18 years after approval by the ethical committee of each site. We recorded the demographic data including gender, age, education, native habitat and the laboratory tests including serum creatinine, albumin, cholesterol, urinalysis, proteinuria, serology tests and the pathological findings. The clinical outcomes including remission, flare, doubling of serum creatinine, renal survival, and patient survival were investigated. Results: We recruited 666 patients performed kidney biopsy during Jul 1, 2014 to Jun 30, 2015. The female to male ratio was 2.16:1. The mean age, creatinine, albumin, and cholesterol were 42 (18-82) years, 1.4 (0.4-13) mg/dL, 2.9+0.8 g/dL, and 296+118 mg/dL in respectively. The median proteinuria was 3.2 g/day and ranged 0-22 g/day. The patients presented with 34% of nephrotic syndrome, 22% of nephritis, 21.7% of nephrotic nephritis, 52% of renal impairment (creatinine > 1.2 mg/dL), and 54.4% of new or aggravated hypertension. The renal pathological findings showed 38% of lupus nephritis (LN), 17.6% of IgA nephropathy (IgAN), 9% of focal segmental glomerulosclerosis (FSGS), and 8.9% of membranous nephropathy (MN). The mean age of LN, IgAN, FSGS, and MN were 34, 38, 46, and 50 years. The average creatinine at biopsy of LN, IgAN, FSGS, and MN were 1.9, 2.4, 2.4, and 1.1 mg/dL. Due to the time limited, the clinical outcomes were not described at this time. Conclusion: Our study described the first three common renal pathological findings including LN, IgAN, and FSGS They were in the working age and presented with the initial renal impairment at kidney biopsy. This might be the severity of the disease or the delay in performing biopsy due to limitation of facility in kidney biopsy procedure and referring system. In addition to the data from Thailand Renal Replacement Therapy (TRT), LN, IgAN, and FSGS were the most common GN causing the ESRD in our country. Early diagnosis and proper management should be improve the clinical outcomes among these patients.
Copyright ผลงานวิชาการเหล่านี้เป็นลิขสิทธิ์ของสถาบันวิจัยระบบสาธารณสุข หากมีการนำไปใช้อ้างอิง โปรดอ้างถึงสถาบันวิจัยระบบสาธารณสุข ในฐานะเจ้าของลิขสิทธิ์ตามพระราชบัญญัติสงวนลิขสิทธิ์สำหรับการนำงานวิจัยไปใช้ประโยชน์ในเชิงพาณิชย์
Fulltext
Thumbnail
Name: hs2230.pdf
Size: 8.217Mb
Format: PDF
Download

User Manual
(* In case of download problems)

Total downloads:
Today: 0
This month: 0
This budget year: 0
This year: 0
All: 253
 

 
 


 
 
Show full item record
Collections
  • Research Reports [2469]

    งานวิจัย


DSpace software copyright © 2002-2016  DuraSpace
Privacy Policy | Contact Us | Send Feedback
Theme by 
Atmire NV
 

 

Browse

HSRI Knowledge BankDashboardCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjectsSubjectsการบริการสุขภาพ (Health Service Delivery) [619]กำลังคนด้านสุขภาพ (Health Workforce) [99]ระบบสารสนเทศด้านสุขภาพ (Health Information Systems) [286]ผลิตภัณฑ์ วัคซีน และเทคโนโลยีทางการแพทย์ (Medical Products, Vaccines and Technologies) [125]ระบบการเงินการคลังด้านสุขภาพ (Health Systems Financing) [158]ภาวะผู้นำและการอภิบาล (Leadership and Governance) [1281]ปัจจัยสังคมกำหนดสุขภาพ (Social Determinants of Health: SDH) [228]วิจัยระบบสุขภาพ (Health System Research) [28]ระบบวิจัยสุขภาพ (Health Research System) [20]

DSpace software copyright © 2002-2016  DuraSpace
Privacy Policy | Contact Us | Send Feedback
Theme by 
Atmire NV